Most Recent
Bed Bath N’ Table scores partial win in IP suit against rival
Intellectual Property 2024-01-16 4:59 pm By Cindy Cameronne

A judge has handed a partial win to homewares brand Bed Bath Nā€™ Table, finding rival House misled consumers by opening a sub-brand called House Bed & Bath but rejecting the retailer’s trade mark infringement claims.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sandoz tries again to invalidate Xarelto patents
Intellectual Property 2023-11-23 11:31 am By Cat Fredenburgh

Novartis unit Sandoz AG has filed an appeal after it was was barred from selling a generic version of top-selling blood clot drug Xarelto and failed to revoke two Bayer patents for the drug.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ACCC calls out Qantas for ‘failure’ to respond to key claims in landmark case
Competition & Consumer Protection 2023-11-08 1:58 pm By Sam Matthews

The ACCC has raised concerns over Qantasā€™ alleged failure to respond to claims in a blockbuster case against the airline over the sale of tickets on cancelled flights.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Court hands win to Boehringer in fight over Zoetis vaccine patents
Intellectual Property 2023-10-03 11:51 pm By Sam Matthews

German drug maker Boehringer has prevailed in its Federal Court fight against US rival Zoetis over the validity of three patents covering pig vaccines.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Drink rivals mull High Court appeals after losing ā€˜Motherā€™ of all trade mark disputes
Intellectual Property 2023-03-22 2:11 pm By Cindy Cameronne

The owners of Mother energy drinks and Vittoria Food & Beverage have both lost their challenges to each other’s ‘Motherland’ and ‘Mothersky’ trade marks and are considering taking the long-running stoush to the High Court.Ā 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ā€˜Not innocentā€™: Boart Longyear can’t avoid tool recall in patent infringement spat
Intellectual Property 2022-11-21 9:28 pm By Cindy Cameronne

Mineral exploration company Boart Longyear has been granted leave to appeal a finding that it infringed a patent for a mining tool, but it can’t avoid a recall of its tools, with a judge saying its actions were ā€œnot uninformed or innocentā€.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Finish detergent maker says trade mark judgment doesn’t wash
Appeals 2022-10-31 2:50 pm By Cat Fredenburgh

The maker of Finish dishwashing products has appealed a judgment that removed two of its trade marks for non-use and rejected its claim that a competitor’s logo was deceptively similar.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Biogen, Pharmacor lay down swords in battle over MS drug patent
Intellectual Property 2022-10-31 11:01 pm By Cat Fredenburgh

Swiss pharmaceutical company Biogen and Australian generic drug maker Pharmacor have dropped their claims against one another in a lawsuit over the patent for MS drug Tecfidera. In an October 14 order by Federal Court Justice Helen Rofe, Biogenā€™s infringement claims and Pharmacorā€™s cross-claims seeking to invalidate the lucrative patent were discontinued by consent without…

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Court finds Globaltech, Boart Longyear infringed mining patent
Intellectual Property 2022-10-10 11:50 pm By Cindy Cameronne

A judge has found mining tool company Globaltech and mineral exploration company Boart Longyear infringed a patent for a mining tool owned by Australian Mud Company.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bayer wants to amend Xarelto patent at centre of Sandoz’s invalidity claim
Intellectual Property 2022-07-15 11:37 am By Christine Caulfield

German pharmaceutical giant Bayer, which is facing a legal bid by generic drug maker Sandoz to invalidate patents covering blood clot drug Xarelto, is seeking to amend one of the patents in dispute.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?